Regarding myeloid subsets, which are maximally represented in mice treated with CTX + Sl-IFN and with Sl-IFN alone (Figure 6E), the therapeutic effect observed upon combined CTX + Sl-IFN seems to correlate with enhanced tissue resident DC (TIDC) and reduced polymorphonuclear-myeloid-derived suppressor-like cell (PMN-MDSC-like) tumor infiltration (Figure 6F). This evidence concerns the gene IFNA1 and neoplasm.